Home > Publications Database > A physically and mentally active lifestyle relates to younger brain and cognitive age > print

001     285481
005     20260309111200.0
024 7 _ |a 10.1007/s11357-025-01764-w
|2 doi
024 7 _ |a 2509-2715
|2 ISSN
024 7 _ |a 0161-9152
|2 ISSN
024 7 _ |a 1574-4647
|2 ISSN
024 7 _ |a 2152-4041
|2 ISSN
024 7 _ |a 2331-3765
|2 ISSN
024 7 _ |a 2331-3773
|2 ISSN
024 7 _ |a 2452-0756
|2 ISSN
024 7 _ |a 2509-2723
|2 ISSN
037 _ _ |a DZNE-2026-00258
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Behrenbruch, Niklas
|0 P:(DE-2719)9002133
|b 0
|e First author
|u dzne
245 _ _ |a A physically and mentally active lifestyle relates to younger brain and cognitive age
260 _ _ |a [Cham]
|c 2025
|b Springer International Publishing
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1773048641_14562
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Resistance to age-related pathological changes (brain maintenance), including Alzheimer’s disease, cerebrovascular disease, and neurodegeneration may promote cognitive resilience in aging. However, how lifestyle and health profiles relate to successful cognitive and brain aging remains poorly understood. In a novel, deeply phenotyped cohort of 211 cognitively unimpaired older adults (age = 71.0 ± 7.4 years, 46% female), we characterized principal components of lifestyle and health using questionnaire, fitness, and blood data. We estimated cognitive age gap (CAG) based on comprehensive neuropsychological data and brain age gap (BAG) based on brain-pathology markers, including plasma biomarkers of Alzheimer’s pathology (pTau217 and Aβ1-42/Aβ1-40), MRI-based measures of white matter hyperintensities, perivascular spaces, and brain atrophy. Regression analyses tested how the observed lifestyle-health profiles were related to CAG and BAG. Seven principal components explained 49% of the variance in health and lifestyle. The second component, characterized by a mentally and physically active life and low cardiovascular risk, was associated with lower CAG (β = − 0.66, p < 0.001) and BAG (β = − 0.52, p = 0.003), reflecting a younger-than-expected brain and cognitive age, respectively. The association of an active lifestyle and lower CAG was partially mediated by BAG. Higher CAG was also associated with other lifestyle components characterized by low mental stimulation. APOE-ε4 carriers exhibited higher BAG. In conclusion, a lifestyle combining low cardiovascular risk, high mental engagement throughout life and high physical activity/fitness is jointly associated with less-than-expected brain pathology and better-than-expected cognitive performance, supporting its involvement in brain maintenance and cognitive resilience to aging.
536 _ _ |a 352 - Disease Mechanisms (POF4-352)
|0 G:(DE-HGF)POF4-352
|c POF4-352
|f POF IV
|x 0
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 1
588 _ _ |a Dataset connected to CrossRef, Journals: pub.dzne.de
700 1 _ |a Schwarck, Svenja
|0 P:(DE-2719)9000379
|b 1
700 1 _ |a Schumann-Werner, Beate
|0 P:(DE-2719)9002320
|b 2
|u dzne
700 1 _ |a Molloy, Eóin N.
|0 P:(DE-2719)9002180
|b 3
700 1 _ |a Garcia Garcia, Berta
|0 P:(DE-2719)2812734
|b 4
|u dzne
700 1 _ |a Hochkeppler, Anne
|0 P:(DE-2719)2812346
|b 5
|u dzne
700 1 _ |a Fischer, Larissa
|0 P:(DE-2719)9002356
|b 6
700 1 _ |a Büchel, Anna-Therese
|b 7
700 1 _ |a Incesoy, Enise I.
|0 P:(DE-2719)9001517
|b 8
700 1 _ |a Bernal, Jose
|0 P:(DE-2719)9001989
|b 9
700 1 _ |a Vockert, Niklas
|0 P:(DE-2719)9000804
|b 10
700 1 _ |a Müller, Patrick
|0 P:(DE-2719)2811487
|b 11
|u dzne
700 1 _ |a Behnisch, Gusalija
|b 12
700 1 _ |a Morgado, Bárbara
|0 P:(DE-2719)9003591
|b 13
700 1 _ |a Esselmann, Hermann
|0 0000-0001-5484-9710
|b 14
700 1 _ |a Seidenbecher, Constanze I.
|0 0000-0002-7433-2716
|b 15
700 1 _ |a Schott, Björn H.
|0 P:(DE-2719)2814326
|b 16
700 1 _ |a Barthel, Henryk
|b 17
700 1 _ |a Sabri, Osama
|0 P:(DE-2719)2814810
|b 18
|u dzne
700 1 _ |a Wiltfang, Jens
|0 P:(DE-2719)2811317
|b 19
700 1 _ |a Kreissl, Michael C.
|0 P:(DE-2719)2812799
|b 20
700 1 _ |a Düzel, Emrah
|0 P:(DE-2719)2000005
|b 21
700 1 _ |a Maass, Anne
|0 P:(DE-2719)2811815
|b 22
|e Last author
773 _ _ |a 10.1007/s11357-025-01764-w
|0 PERI:(DE-600)2886418-9
|p na
|t GeroScience
|v aop
|y 2025
|x 2509-2715
856 4 _ |u https://pub.dzne.de/record/285481/files/DZNE-2026-00258%20SUP.docx
856 4 _ |y OpenAccess
|u https://pub.dzne.de/record/285481/files/DZNE-2026-00258.pdf
856 4 _ |u https://pub.dzne.de/record/285481/files/DZNE-2026-00258%20SUP.doc
856 4 _ |u https://pub.dzne.de/record/285481/files/DZNE-2026-00258%20SUP.odt
856 4 _ |u https://pub.dzne.de/record/285481/files/DZNE-2026-00258%20SUP.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://pub.dzne.de/record/285481/files/DZNE-2026-00258.pdf?subformat=pdfa
876 7 _ |a #732
|c 2600.00
|e Hybrid-OA
|d 2026-03-09
|j DEAL
909 C O |o oai:pub.dzne.de:285481
|p openaire
|p open_access
|p OpenAPC_DEAL
|p driver
|p VDB
|p openCost
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 0
|6 P:(DE-2719)9002133
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 2
|6 P:(DE-2719)9002320
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 4
|6 P:(DE-2719)2812734
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 5
|6 P:(DE-2719)2812346
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 6
|6 P:(DE-2719)9002356
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 8
|6 P:(DE-2719)9001517
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 9
|6 P:(DE-2719)9001989
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 10
|6 P:(DE-2719)9000804
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 11
|6 P:(DE-2719)2811487
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 13
|6 P:(DE-2719)9003591
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 16
|6 P:(DE-2719)2814326
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 18
|6 P:(DE-2719)2814810
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 19
|6 P:(DE-2719)2811317
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 20
|6 P:(DE-2719)2812799
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 21
|6 P:(DE-2719)2000005
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 22
|6 P:(DE-2719)2811815
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-352
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Disease Mechanisms
|x 0
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 1
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2025-01-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2025-01-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2025-01-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2025-01-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2025-01-06
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b GEROSCIENCE : 2022
|d 2025-01-06
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2025-01-06
915 _ _ |a DEAL Springer
|0 StatID:(DE-HGF)3002
|2 StatID
|d 2025-01-06
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2025-01-06
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2025-01-06
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b GEROSCIENCE : 2022
|d 2025-01-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2025-01-06
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2025-01-06
915 p c |a APC keys set
|2 APC
|0 PC:(DE-HGF)0000
915 p c |a Local Funding
|2 APC
|0 PC:(DE-HGF)0001
920 1 _ |0 I:(DE-2719)1311001
|k AG Maaß
|l Multimodal Neuroimaging
|x 0
920 1 _ |0 I:(DE-2719)5000006
|k AG Düzel
|l Clinical Neurophysiology and Memory
|x 1
920 1 _ |0 I:(DE-2719)1410006
|k AG Wiltfang
|l Molecular biomarkers for predictive diagnostics of neurodegenerative diseases
|x 2
920 1 _ |0 I:(DE-2719)1410002
|k AG Fischer
|l Epigenetics and Systems Medicine in Neurodegenerative Diseases
|x 3
920 1 _ |0 I:(DE-2719)1340016
|k Core MR PET
|l Core MR PET
|x 4
980 1 _ |a FullTexts
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)1311001
980 _ _ |a I:(DE-2719)5000006
980 _ _ |a I:(DE-2719)1410006
980 _ _ |a I:(DE-2719)1410002
980 _ _ |a I:(DE-2719)1340016
980 _ _ |a APC

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21